IUPAC/Chemical Name
Benzo(h)(1)benzopyrano(5,4,3-cde)(1)benzopyran-5,12-dione, 6,10-dihydroxy-1-methyl-
InChi Key
UVQJAVUEWNSVSK-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H10O6/c1-7-5-6-10-13-11(7)18(22)25-17-12-8(3-2-4-9(12)20)16(21)15(14(13)17)19(23)24-10/h2-6,20-21H,1H3
SMILES Code
O=C1OC2=C(C3=C1C(O)=C4C(C(O)=CC=C4)=C3O5)C(C5=O)=C(C)C=C2
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
334.28
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Unzner TA, Grossmann AS, Magauer T. Rapid Access to Orthogonally Functionalized Naphthalenes: Application to the Total Synthesis of the Anticancer Agent Chartarin. Angew Chem Int Ed Engl. 2016 Aug 8;55(33):9763-7. doi: 10.1002/anie.201605071. Epub 2016 Jun 29. PMID: 27355517.
2: Poochikian GK, Cradock JC. Enhanced chartreusin solubility by hydroxybenzoate hydrotropy. J Pharm Sci. 1979 Jun;68(6):728-32. doi: 10.1002/jps.2600680620. PMID: 458574.
3: Barceló F, Portugal J. Elsamicin A binding to DNA. A comparative thermodynamic characterization. FEBS Lett. 2004 Oct 8;576(1-2):68-72. doi: 10.1016/j.febslet.2004.08.063. PMID: 15474012.
4: Xu Z, Jakobi K, Welzel K, Hertweck C. Biosynthesis of the antitumor agent chartreusin involves the oxidative rearrangement of an anthracyclic polyketide. Chem Biol. 2005 May;12(5):579-88. doi: 10.1016/j.chembiol.2005.04.017. PMID: 15911378.
5: Uesugi M, Sekida T, Matsuki S, Sugiura Y. Selective DNA cleavage by elsamicin A and switch function of its amino sugar group. Biochemistry. 1991 Jul 9;30(27):6711-5. doi: 10.1021/bi00241a011. PMID: 1648389.
6: Párraga A, Orozco M, Portugal J. Experimental and modelling studies on the DNA cleavage by elsamicin A. Eur J Biochem. 1992 Sep 1;208(2):227-33. doi: 10.1111/j.1432-1033.1992.tb17177.x. PMID: 1325899.
7: Konishi M, Sugawara K, Kofu F, Nishiyama Y, Tomita K, Miyaki T, Kawaguchi H. Elsamicins, new antitumor antibiotics related to chartreusin. I. Production, isolation, characterization and antitumor activity. J Antibiot (Tokyo). 1986 Jun;39(6):784-91. doi: 10.7164/antibiotics.39.784. PMID: 3733527.
8: Weissman K. A new origin for chartreusin. Chem Biol. 2005 May;12(5):512-4. doi: 10.1016/j.chembiol.2005.05.004. PMID: 15911371.
